Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

<p>Abstract</p> <p>Background</p> <p>Despite the overall high degree of response to pharmacotherapy, consensus is lacking on how to judge clinical response or define optimal treatment/remission when treating adults with attention-deficit/hyperactivity disorder (ADHD). T...

Full description

Bibliographic Details
Main Authors: Mattingly Greg W, Weisler Richard H, Young Joel, Adeyi Ben, Dirks Bryan, Babcock Thomas, Lasser Robert, Scheckner Brian, Goodman David W
Format: Article
Language:English
Published: BMC 2013-01-01
Series:BMC Psychiatry
Subjects:
Lisdexamfetamine dimesylate (LDX)
Attention-deficit/hyperactivity disorder (ADHD)
Adults
Response
Remission
Online Access:http://www.biomedcentral.com/1471-244X/13/39

Similar Items

Similar Items